Adult T-cell leukemia–lymphoma (ATL) is a peripheral T-cell malignancy, closely associated with human T-cell lymphotropic virus type I infection. Clinically, ATL is classified into four subtypes ...

Adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) face significant survival disparities and ...

Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive form ... challenging due to high rates of relapse, particularly in adult patients. T-ALL pathogenesis involves a series of genetic ...

You'll get high doses of chemotherapy to destroy as many leukemia blast cells ... adult AML is treated with external radiation therapy, which is given from outside of your body. If AML treatments ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...

Positive CHMP opinion based on FELIX clinical trial of obecabtagene autoleucel (obe-cel) in adult patients with r/r B-ALL, demonstrating high and durable response rates and low toxicityOpinion follows ...

adult T-cell leukemia–lymphoma (ATL) is first divided into two groups: indolent (i.e., smoldering or chronic type) or aggressive (i.e., acute or lymphoma type). The prognosis of indolent ATL is ...